Cargando…

P1.12-03 Computed Tomography-based Artificial Intelligence System in the Diagnosis of COVID-19

Detalles Bibliográficos
Autores principales:	Kahya, Y., Orhan, K., Yan, H., Gursoy Coruh, A., Liu, P., Kayi Cangir, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	P1.12 Management of Lung Cancer in the Era of Covid-19, Sunday, August 7, 2022 - 17:00 - 19:00
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452017/ http://dx.doi.org/10.1016/j.jtho.2022.07.187

Ejemplares similares

P1.12-01 Lung Cancer Screening in the COVID-19 Era: Understanding Program-Level Impact
por: Lutzow, L.K., et al.
Publicado: (2022)

P1.12-04 The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers
por: Seguí, E., et al.
Publicado: (2022)

P1.12-02 The Impact of COVID-19 on Quality of Care for Lung Cancer - Analyses of Prospective Clinical Data from The EnRICH Cohort
por: Brown, B., et al.
Publicado: (2022)

P1.12-05 Prediction of Clinically Significant Pathological Upstaging in Resected Lung Cancer: Insight from COVID-19 Pandemic (1st wave)
por: Zhang, Y.Z., et al.
Publicado: (2022)

Développement et validation d’un nomogramme pour prédire l’acceptation de la vaccination contre le SARS-CoV2 chez les patients atteints de cancer
por: Gal, J., et al.
Publicado: (2021)

OA17.03 Depression, Anxiety, and Distress Impact in Patients With Thoracic Malignancies During the COVID-19 Pandemic
por: Arrieta, O., et al.
Publicado: (2021)

P34.03 Lung Cancer Patients and COVID-19 in a District General Hospital in the UK
por: Aujayeb, A.
Publicado: (2021)

P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
por: Cudero, L., et al.
Publicado: (2021)

Risk of sarcopoenia and prevention of disability in post COVID 19 elderly patients
por: D'Amico, Ferdinando, et al.
Publicado: (2021)

Structures of mycobacterial ATP synthase bound to inhibitors
por: Courbon, Gautier M., et al.
Publicado: (2022)

FP06.03 COVID-19: Does Thoracic Surgery Increase Mortality Rates during the Pandemic?
por: Tsukazan, M.T., et al.
Publicado: (2021)

MA12.03 A Thoracic Cancers International COVID 19 Collaboration Survey on Patients’ Perceptions of COVID-19 (Teravolt-Paper)
por: Wong, S., et al.
Publicado: (2021)

OA17.01 Core Supportive Care for People Living With Lung Cancer During COVID-19: Analyses of Specialist Lung Cancer Nursing Practice
por: Brunelli, V.
Publicado: (2021)

OA17.02 COVID-19 Pandemic and Mental Health Status of Lung Cancer Patients in Indonesia
por: Afladhia, H., et al.
Publicado: (2021)

OA17.04 The Global Impact of COVID-19 on Telehealth and Care for Persons With Thoracic Cancers
por: Smeltzer, M., et al.
Publicado: (2021)

OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
por: Mack, P.C., et al.
Publicado: (2022)

P33.01 Air Leak Due COVID-19 in a Lung Cancer Patient
por: Aujayeb, A.
Publicado: (2021)

CRT-200.03 The Impact of Myocardial Infarction During Hospitalization on the Prognosis of Patients with Covid-19
por: Tateishi, Kazuya, et al.
Publicado: (2023)

P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021)

P34.05 Three Birds, One Stone: IVIG Use in Hypogammaglobulinemia, Checkpoint Inhibitor Pneumonitis, and Persistent COVID-19
por: Olson, E., et al.
Publicado: (2021)

P34.01 6-Weekly vs 3-Weekly Pembrolizumab – Toxicities and Tolerance in The COVID-era
por: Douglas, C., et al.
Publicado: (2021)

P31.05 SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
por: Tsukazan, M.T., et al.
Publicado: (2021)

P34.02 The Inhibitory Effect of Cisplatin, Paclitaxel, and Pemetrexed on the Growth of PC9GR Cells During the COVID-19 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P34.06 Antiproliferative Effects of Paclitaxel on PC9-MET Cells During the Coronavirus Disease 2019 Pandemic
por: Mohiuddin, M., et al.
Publicado: (2021)

P31.06 Impact of Covid-19 Infection on Lung Cancer Patients: Experience in Latin-American Country ACHOCC-19L Study
por: Ospina Serrano, A.V., et al.
Publicado: (2021)

P31.04 Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study
por: Patel, A., et al.
Publicado: (2021)

P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
por: Araujo, A., et al.
Publicado: (2021)

BURDEN AND SEVERITY OF COVID-19 IN CHILDREN HOSPITALISED OVER FIVE COVID-19 WAVES IN SOWETO, SOUTH AFRICA
por: Moore, D., et al.
Publicado: (2023)

CLOSTRIDIUM DIFFICILLAE INFECTION IN POST-COVID PATIENTS
por: Cveková, S., et al.
Publicado: (2023)

EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL
por: Wressnigg, N., et al.
Publicado: (2023)

EFFECT OF HYBRID IMMUNITY, SCHOOL REOPENING, AND THE OMICRON VARIANT ON TRAJECTORY OF COVID-19 EPIDEMIC IN INDIA: A MODELLING STUDY
por: Mozaffer, F., et al.
Publicado: (2023)

COVID-19 ASSOCIATED HEPATITIS IN CHILDREN (CAH-C) DURING THE RISE OF DELTA VARIANT IN INDIA: A NEW COVID-19 COMPLICATION OR A SUPERINFECTION.
por: Rawat, S., et al.
Publicado: (2023)

MODELLING THE IMPACT OF COVID-19 AND ROUTINE MENACWY VACCINATION ON MENINGOCOCCAL CARRIAGE AND DISEASE IN THE UK.
por: Hadley, L., et al.
Publicado: (2023)

HIGH RATE OF MULTIDRUG RESISTANT BACTERIAL INFECTIONS IN CRITICALLY ILL COVID-19 PATIENTS ADMITTED AT THE PEAK OF PANDEMIC IN A NATIONAL REFERRAL HOSPITAL, KENYA
por: Mutua, J., et al.
Publicado: (2023)

A RAPID POINT-OF-CARE DIPSTICK ASSAY FOR DIFFERENTIATION OF SARS-COV-2 VARIANTS IN COVID-19 PATIENTS
por: Paul, D., et al.
Publicado: (2023)

Incidence of and Risk Factors Associated with Postoperative Venous Thromboembolism in Hysterectomy for Benign Indications
por: Duyar, S., et al.
Publicado: (2020)

P32.02 2020 in Hindsight: Newly Diagnosed Lung Cancer Patients in the Time of COVID-19 at a Tertiary Canadian Cancer Centre
por: Petersen, L., et al.
Publicado: (2021)

P32.01 Clinical Screening for COVID-19 in Asymptomatic Patients With Lung Cancer: Brazilian Experience From a Single Institution
por: Teixeira, C.H., et al.
Publicado: (2021)

High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients
por: Pelizzaro, F., et al.
Publicado: (2021)

Cohorte de suivi des patients ayant présenté une embolie pulmonaire dans le cadre d’une infection à COVID-19
por: Doutrelon, Caroline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vk7guesejbhdut85kuo0uvgv0g